(*) EU Approval Date: 2004. 09.22.
(*) USA Approval Date: 2000. 12.15.
>Bivalirudin for Inj.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Expiration: 2028. 07.27.
Patent>Total USA No.: 6
Patent>UpDate: 2018. 01.23
TradeMark
TradeMark Web-Site